GLP-1 Medications & Perimenopause Brook Ahnemann, ND Perimenopause a gradual transition in the years before menopause is a period of big hormonal swings
Participants received once-weekly subcutaneous injections of retatrutide at varying doses or placebo over 24 weeks, with a structured dose-escalation period built into the protocol to improve tolerability
Remember to label the date you opened the medication since it's only suitable for 28 days after opening
The potential impact of current and proposed tariffs poses significant challenges for brand name and generic natural desiccated thyroid (NDT) drugs
Clin Dermatol
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday